Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.
Ahmad SS, Verma R, Commons RJ, Nitika, Singh-Phulgenda S, Chhajed R, Bharti PK, Behera B, Naser SM, Pal SK, Ranjit PH, Baharia RK, Solanki B, Upadhyay KJ, Guerin PJ, Sharma A, Price RN, Rahi M, Thriemer K. Ahmad SS, et al. Among authors: guerin pj. Trials. 2024 Feb 29;25(1):154. doi: 10.1186/s13063-024-07987-0. Trials. 2024. PMID: 38424577 Free PMC article.
Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis.
Kumar R, Dahal P, Singh-Phulgenda S, Siddiqui NA, Munir A, Naylor C, Wilson J, Buck G, Rahi M, Malaviya P, Alves F, Sundar S, Ritmeijer K, Stepniewska K, Guérin PJ, Pandey K. Kumar R, et al. Among authors: guerin pj. BMJ Open. 2023 Oct 28;13(10):e074679. doi: 10.1136/bmjopen-2023-074679. BMJ Open. 2023. PMID: 37898487 Free PMC article.
Haematological dynamics following treatment of visceral leishmaniasis: a protocol for systematic review and individual participant data (IPD) meta-analysis.
Munir A, Dahal P, Kumar R, Singh-Phulgenda S, Siddiqui NA, Naylor C, Wilson J, Buck G, Rahi M, Alves F, Malaviya P, Sundar S, Ritmeijer K, Stepniewska K, Pandey K, Guérin PJ, Musa A. Munir A, et al. Among authors: guerin pj. BMJ Open. 2023 Dec 14;13(12):e074841. doi: 10.1136/bmjopen-2023-074841. BMJ Open. 2023. PMID: 38101841 Free PMC article.
The lymphatic filariasis treatment study landscape: A systematic review of study characteristics and the case for an individual participant data platform.
Freitas LT, Khan MA, Uddin A, Halder JB, Singh-Phulgenda S, Raja JD, Balakrishnan V, Harriss E, Rahi M, Brack M, Guérin PJ, Basáñez MG, Kumar A, Walker M, Srividya A. Freitas LT, et al. Among authors: guerin pj. PLoS Negl Trop Dis. 2024 Jan 16;18(1):e0011882. doi: 10.1371/journal.pntd.0011882. eCollection 2024 Jan. PLoS Negl Trop Dis. 2024. PMID: 38227595 Free PMC article.
Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review.
Chhajed R, Dahal P, Singh-Phulgenda S, Brack M, Naylor C, Sundar S, Alves F, Stepniewska K, Guerin PJ. Chhajed R, et al. Among authors: guerin pj. Lancet Reg Health Southeast Asia. 2023 Dec 6;22:100317. doi: 10.1016/j.lansea.2023.100317. eCollection 2024 Mar. Lancet Reg Health Southeast Asia. 2023. PMID: 38482151 Free PMC article.
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.
Singh-Phulgenda S, Kumar R, Dahal P, Munir A, Rashan S, Chhajed R, Naylor C, Maguire BJ, Siddiqui NA, Harriss E, Rahi M, Alves F, Sundar S, Stepniewska K, Musa A, Guerin PJ, Pandey K. Singh-Phulgenda S, et al. Among authors: guerin pj. PLoS Negl Trop Dis. 2024 Apr 16;18(4):e0011635. doi: 10.1371/journal.pntd.0011635. eCollection 2024 Apr. PLoS Negl Trop Dis. 2024. PMID: 38626228 Free PMC article.
Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis.
WorldWide Antimalarial Resistance Network White Blood Cell Count in Malaria Study Group. WorldWide Antimalarial Resistance Network White Blood Cell Count in Malaria Study Group. Malar J. 2023 Jun 6;22(1):174. doi: 10.1186/s12936-023-04583-6. Malar J. 2023. PMID: 37280686 Free PMC article.
Spatio-temporal spread of artemisinin resistance in Southeast Asia.
Flegg JA, Kandanaarachchi S, Guerin PJ, Dondorp AM, Nosten FH, Otienoburu SD, Golding N. Flegg JA, et al. Among authors: guerin pj. PLoS Comput Biol. 2024 Apr 16;20(4):e1012017. doi: 10.1371/journal.pcbi.1012017. eCollection 2024 Apr. PLoS Comput Biol. 2024. PMID: 38626207 Free PMC article.
Prevalence of asymptomatic parasitaemia among household members of children under seasonal malaria chemoprevention coverage and comparison of the performance of standard rapid diagnostic tests versus ultrasensitive RDT for the detection of asymptomatic parasitaemia in Nanoro, Burkina Faso.
Kambou SAE, Millogo KS, Sondo P, Kabore B, Kouevi AFC, Bouda I, Rouamba T, Derra K, Tahita MC, Ilboudo H, Rouamba E, Tougri G, Otienoburu SD, Dhorda M, Bamba S, Guerin PJ, Tinto H. Kambou SAE, et al. Among authors: guerin pj. Parasitol Res. 2024 Nov 15;123(11):383. doi: 10.1007/s00436-024-08380-1. Parasitol Res. 2024. PMID: 39542934 Free PMC article.
222 results